ArticleInternational journal of cancer2016

STAT3 polymorphisms may predict an unfavorable response to first-line platinum-based therapy for women with advanced serous epithelial ovarian cancer.

Jennifer Permuth-Wey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.